The mice injected with control RNAs initiated tumors (3/3 mice) within 12 weeks, whereas no tumor formation was observed in mice injected with the miR-589-5p mimic, suggesting that miR-589-5p suppresses the CD90+ CSC characteristics both in vitro and in vivo. Here, THY1 is linked to neoplasm.